Vijay Prabhu, V., Madhukar, N., Gilvary, C., Kline, C. L. B., Tarapore, R., El-Deiry, W., . . . Allen, J. (2018). DRES-10. DRD5 IS A MODULATOR OF GLIOMA SUSCEPTIBILITY TO DRD2 ANTAGONISM BY ONC201. Neuro Oncol.
Chicago Style CitationVijay Prabhu, Varun, et al. "DRES-10. DRD5 IS A MODULATOR OF GLIOMA SUSCEPTIBILITY TO DRD2 ANTAGONISM BY ONC201." Neuro Oncol 2018.
Cita MLAVijay Prabhu, Varun, et al. "DRES-10. DRD5 IS A MODULATOR OF GLIOMA SUSCEPTIBILITY TO DRD2 ANTAGONISM BY ONC201." Neuro Oncol 2018.
Atenció: Aquestes cites poden no estar 100% correctes.